(858) 366-8608

®

®

AnaBios’ Internal Drug Discovery Programs

AnaBios is utilizing human-based Phase-X   technology and the expertise of its scientists in drug de-risking to advance proprietary drug discovery programs. The discovery compounds have been in-licensed, at different preclinical stages, from partnering organizations. By employing the Phase-X   approach, AnaBios is rapidly progressing the molecules through lead optimization and clinical candidate selection. The compounds will then be introduced into clinical studies with AnaBios’ strategic partners.

Drug Discovery Program